IMDX Financials

Insight Molecular Diagnostics Inc - Financial statements & key metrics

Stock Price

$3.61

Market Cap

$96.50M

EPS

$-1.65

Income Statement Highlights

Most Recent Quarter: 2024-12-31

Revenue

$1.88M

Gross Profit

Operating Income

Net Income

$-60.66M

EPS (Diluted)

$-4.66

Balance Sheet Highlights

Total Assets

$35.08M

Total Liabilities

$47.35M

Shareholders Equity

Cash & Equivalents

$8.64M

Total Debt

Cash Flow Highlights

Operating Cash Flow

$-20.71M

CapEx

Free Cash Flow

Profitability Metrics

Gross Margin

56.8%

Operating Margin

-8.7%

ROE

-236.0%

View Complete Financial Statements

Full income statements, balance sheets, and cash flows for multiple periods

Open Full Financials

Frequently Asked Questions

What is IMDX revenue?

IMDX's most recent quarterly revenue was $1.88M. Annual revenue can be calculated by summing the four most recent quarters.

Is IMDX profitable?

IMDX reported a loss of $60.66M in the most recent quarter.

What is IMDX market cap?

IMDX has a market capitalization of $96.50M, making it a small-cap stock.

Does IMDX have debt?

View IMDX's balance sheet for debt information.

What is IMDX cash flow?

Cash flow data is available in the full financial statements.